ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fertility Enhancing Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-15J811
Home | Market Reports | Health| Reproductive Health
Global Fertility Enhancing Treatment Market Size Status and Forecast 2021 2027
BUY CHAPTERS

Global Fertility Enhancing Treatment Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-15J811
Report
July 2025
Pages:139
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Church Dwight
SASMAR
BioFilm
FAIRHAVEN HEALTH
The YES YES Company

Fertility Enhancing Treatment Market Size

In 2024, the global market size of Fertility Enhancing Treatment was estimated to be worth US$ 5577 million and is forecast to reach approximately US$ 8447 million by 2031 with a CAGR of 6.2% during the forecast period 2025-2031.

Fertility Enhancing Treatment Market

Fertility Enhancing Treatment Market

Infertility Drugs are drugs which enhance reproductive fertility. For women, Infertility Drugs is used to stimulate follicle development of the ovary. Agents that enhance ovarian activity can be classified as either Gonadotropin releasing hormone, Estrogen antagonists or Gonadotropins.
Global Fertility Enhancing Treatment key players include Merck, Ferring, MSD, LIVZON, Abbott, etc. Global top five manufacturers hold a share about 60%.
North America is the largest market, with a share over 30%, followed by China, and Europe, both have a share about 40 percent.
In terms of product, Fertility Drugs for Women is the largest segment, with a share over 85%. And in terms of application, the largest application is Drug Stores, followed by Hospitals, Online, etc.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Fertility Enhancing Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fertility Enhancing Treatment.
The Fertility Enhancing Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Fertility Enhancing Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fertility Enhancing Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Market Segmentation

Scope of Fertility Enhancing Treatment Market Report

Report Metric Details
Report Name Fertility Enhancing Treatment Market
Forecasted market size in 2031 approximately US$ 8447 million
CAGR 6.2%
Forecasted years 2025 - 2031
Segment by Type
  • Fertility Drugs for Women
  • Fertility Drugs for Men
  • OTC Conception Gels/Lubricants
Segment by Application
  • Hospitals
  • Drug Stores
  • Online
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Merck, Ferring, MSD, LIVZON, Abbott, Bayer Zydus Pharma, Church＆Dwight, SASMAR, BioFilm,Inc, FAIRHAVEN HEALTH, The YES YES Company
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.
  • Chapter 2: Revenue of Fertility Enhancing Treatment in global and regional level.
  • Chapter 3: Detailed analysis of Fertility Enhancing Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Fertility Enhancing Treatment revenue, gross margin, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 8: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion

FAQ for this report

What is the Fertility Enhancing Treatment Market size in 2031?

Ans: The Fertility Enhancing Treatment Market size in 2031 will be approximately US$ 8447 million.

What is the market share of major companies in Fertility Enhancing Treatment Market?

Ans: Global top five manufacturers hold a share about 60%.

What is the Fertility Enhancing Treatment Market share by type?

Ans: In terms of product, Fertility Drugs for Women is the largest segment, with a share over 85%.

Who are the main players in the Fertility Enhancing Treatment Market report?

Ans: The main players in the Fertility Enhancing Treatment Market are Merck, Ferring, MSD, LIVZON, Abbott, Bayer Zydus Pharma, Church＆Dwight, SASMAR, BioFilm,Inc, FAIRHAVEN HEALTH, The YES YES Company

What are the Application segmentation covered in the Fertility Enhancing Treatment Market report?

Ans: The Applications covered in the Fertility Enhancing Treatment Market report are Hospitals, Drug Stores, Online

What are the Type segmentation covered in the Fertility Enhancing Treatment Market report?

Ans: The Types covered in the Fertility Enhancing Treatment Market report are Fertility Drugs for Women, Fertility Drugs for Men, OTC Conception Gels/Lubricants

1 Study Coverage
1.1 Fertility Enhancing Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Fertility Enhancing Treatment Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Fertility Drugs for Women
1.2.3 Fertility Drugs for Men
1.2.4 OTC Conception Gels/Lubricants
1.3 Market by Application
1.3.1 Global Fertility Enhancing Treatment Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Hospitals
1.3.3 Drug Stores
1.3.4 Online
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fertility Enhancing Treatment Market Size Estimates and Forecasts
2.2 Fertility Enhancing Treatment Market Size by Region: 2024 Versus 2031
2.2.1 Global Fertility Enhancing Treatment Revenue by Region: 2020-2025
2.2.2 Global Fertility Enhancing Treatment Revenue Forecast by Region (2026-2031)
2.2.3 Global Fertility Enhancing Treatment Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Fertility Enhancing Treatment Revenue by Type (2020-2031)
3.1.2 Global Fertility Enhancing Treatment Revenue Market Share by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Fertility Enhancing Treatment Revenue by Application (2020-2031)
3.2.2 Global Fertility Enhancing Treatment Revenue Market Share by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Fertility Drugs for Women of Fertility Enhancing Treatment Revenue Market Share by Application
3.3.2 Fertility Drugs for Men of Fertility Enhancing Treatment Revenue Market Share by Application
3.3.3 OTC Conception Gels/Lubricants of Fertility Enhancing Treatment Revenue Market Share by Application
4 Global Fertility Enhancing Treatment by Company
4.1 Global Fertility Enhancing Treatment Revenue by Company (2020-2025)
4.2 Global Fertility Enhancing Treatment Revenue Share by Company (2020-2025)
4.3 Competitive Landscape
4.3.1 Key Fertility Enhancing Treatment Companies around the World: Ranking by Revenue
4.3.2 Global Fertility Enhancing Treatment Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.3.3 Global Fertility Enhancing Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.4 Global Fertility Enhancing Treatment Companies Headquarters & Product Type
4.4.1 Global Fertility Enhancing Treatment Companies Headquarters
4.4.2 Date of International Companies Enter into Fertility Enhancing Treatment Market
4.4.3 Global Fertility Enhancing Treatment Companies Product & Service
4.4.4 Fertility Drugs for Women Revenue Market Share of Fertility Enhancing Treatment by Company
4.4.5 Fertility Drugs for Men Revenue Market Share of Fertility Enhancing Treatment by Company
4.4.6 OTC Conception Gels/Lubricants Revenue Market Share of Fertility Enhancing Treatment by Company
4.5 Global Fertility Enhancing Treatment Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Merck
5.1.1 Merck Corporation Information
5.1.2 Merck Description, Business Overview
5.1.3 Merck Fertility Enhancing Treatment Products Offered
5.1.4 Merck Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.1.5 Merck Fertility Enhancing Treatment Revenue by Product in 2024
5.1.6 Merck Fertility Enhancing Treatment Revenue by Application in 2024
5.1.7 Merck Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.1.8 Merck Recent Developments
5.2 Ferring
5.2.1 Ferring Corporation Information
5.2.2 Ferring Description, Business Overview
5.2.3 Ferring Fertility Enhancing Treatment Products Offered
5.2.4 Ferring Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.2.5 Ferring Fertility Enhancing Treatment Revenue by Product in 2024
5.2.6 Ferring Fertility Enhancing Treatment Revenue by Application in 2024
5.2.7 Ferring Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.2.8 Ferring Recent Developments
5.3 MSD
5.3.1 MSD Corporation Information
5.3.2 MSD Description, Business Overview
5.3.3 MSD Fertility Enhancing Treatment Products Offered
5.3.4 MSD Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.3.5 MSD Fertility Enhancing Treatment Revenue by Product in 2024
5.3.6 MSD Fertility Enhancing Treatment Revenue by Application in 2024
5.3.7 MSD Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.3.8 MSD Recent Developments
5.4 LIVZON
5.4.1 LIVZON Corporation Information
5.4.2 LIVZON Description, Business Overview
5.4.3 LIVZON Fertility Enhancing Treatment Products Offered
5.4.4 LIVZON Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.4.5 LIVZON Fertility Enhancing Treatment Revenue by Product in 2024
5.4.6 LIVZON Fertility Enhancing Treatment Revenue by Application in 2024
5.4.7 LIVZON Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.4.8 LIVZON Recent Developments
5.5 Abbott
5.5.1 Abbott Corporation Information
5.5.2 Abbott Description, Business Overview
5.5.3 Abbott Fertility Enhancing Treatment Products Offered
5.5.4 Abbott Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.5.5 Abbott Fertility Enhancing Treatment Revenue by Product in 2024
5.5.6 Abbott Fertility Enhancing Treatment Revenue by Application in 2024
5.5.7 Abbott Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.5.8 Abbott Recent Developments
5.6 Bayer Zydus Pharma
5.6.1 Bayer Zydus Pharma Corporation Information
5.6.2 Bayer Zydus Pharma Description, Business Overview
5.6.3 Bayer Zydus Pharma Fertility Enhancing Treatment Products Offered
5.6.4 Bayer Zydus Pharma Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.6.5 Bayer Zydus Pharma Fertility Enhancing Treatment Revenue by Product in 2024
5.6.6 Bayer Zydus Pharma Fertility Enhancing Treatment Revenue by Application in 2024
5.6.7 Bayer Zydus Pharma Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.6.8 Bayer Zydus Pharma Recent Developments
5.7 Church＆Dwight
5.7.1 Church＆Dwight Corporation Information
5.7.2 Church＆Dwight Description, Business Overview
5.7.3 Church＆Dwight Fertility Enhancing Treatment Products Offered
5.7.4 Church＆Dwight Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.7.5 Church＆Dwight Fertility Enhancing Treatment Revenue by Product in 2024
5.7.6 Church＆Dwight Fertility Enhancing Treatment Revenue by Application in 2024
5.7.7 Church＆Dwight Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.7.8 Church＆Dwight Recent Developments
5.8 SASMAR
5.8.1 SASMAR Corporation Information
5.8.2 SASMAR Description, Business Overview
5.8.3 SASMAR Fertility Enhancing Treatment Products Offered
5.8.4 SASMAR Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.8.5 SASMAR Fertility Enhancing Treatment Revenue by Product in 2024
5.8.6 SASMAR Fertility Enhancing Treatment Revenue by Application in 2024
5.8.7 SASMAR Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.8.8 SASMAR Recent Developments
5.9 BioFilm,Inc
5.9.1 BioFilm,Inc Corporation Information
5.9.2 BioFilm,Inc Description, Business Overview
5.9.3 BioFilm,Inc Fertility Enhancing Treatment Products Offered
5.9.4 BioFilm,Inc Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.9.5 BioFilm,Inc Fertility Enhancing Treatment Revenue by Product in 2024
5.9.6 BioFilm,Inc Fertility Enhancing Treatment Revenue by Application in 2024
5.9.7 BioFilm,Inc Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.9.8 BioFilm,Inc Recent Developments
5.10 FAIRHAVEN HEALTH
5.10.1 FAIRHAVEN HEALTH Corporation Information
5.10.2 FAIRHAVEN HEALTH Description, Business Overview
5.10.3 FAIRHAVEN HEALTH Fertility Enhancing Treatment Products Offered
5.10.4 FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.10.5 FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue by Product in 2024
5.10.6 FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue by Application in 2024
5.10.7 FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.10.8 FAIRHAVEN HEALTH Recent Developments
5.11 The YES YES Company
5.11.1 The YES YES Company Corporation Information
5.11.2 The YES YES Company Description, Business Overview
5.11.3 The YES YES Company Fertility Enhancing Treatment Products Offered
5.11.4 The YES YES Company Fertility Enhancing Treatment Revenue and Gross Margin (2020-2025)
5.11.5 The YES YES Company Fertility Enhancing Treatment Revenue by Product in 2024
5.11.6 The YES YES Company Fertility Enhancing Treatment Revenue by Application in 2024
5.11.7 The YES YES Company Fertility Enhancing Treatment Revenue by Geographic Area in 2024
5.11.8 The YES YES Company Recent Developments
6 North America
6.1 North America Fertility Enhancing Treatment Market Size YoY Growth 2020-2031
6.2 North America Fertility Enhancing Treatment Market Facts & Figures by Country (2020-2031)
6.3 North America Fertility Enhancing Treatment Revenue by Type (2020-2025)
6.4 North America Fertility Enhancing Treatment Revenue by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Fertility Enhancing Treatment Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Fertility Enhancing Treatment Market Facts & Figures by Region (2020-2031)
7.3 Asia-Pacific Fertility Enhancing Treatment Revenue by Type (2020-2025)
7.4 Asia-Pacific Fertility Enhancing Treatment Revenue by Application (2020-2025)
8 Europe
8.1 Europe Fertility Enhancing Treatment Market Size YoY Growth 2020-2031
8.2 Europe Fertility Enhancing Treatment Market Facts & Figures by Country (2020-2031)
8.3 Europe Fertility Enhancing Treatment Revenue by Type (2020-2025)
8.4 Europe Fertility Enhancing Treatment Revenue by Application (2020-2025)
9 Latin America
9.1 Latin America Fertility Enhancing Treatment Market Size YoY Growth 2020-2031
9.2 Latin America Fertility Enhancing Treatment Market Facts & Figures by Country (2020-2031)
9.3 Latin America Fertility Enhancing Treatment Revenue by Type (2020-2025)
9.4 Latin America Fertility Enhancing Treatment Revenue by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Fertility Enhancing Treatment Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Fertility Enhancing Treatment Market Facts & Figures by Country (2020-2031)
10.3 Middle East and Africa Fertility Enhancing Treatment Revenue by Type (2020-2025)
10.4 Middle East and Africa Fertility Enhancing Treatment Revenue by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Fertility Enhancing Treatment Supply Chain Analysis
11.2 Fertility Enhancing Treatment Key Raw Materials and Upstream Suppliers
11.3 Fertility Enhancing Treatment Clients Analysis
11.4 Fertility Enhancing Treatment Sales Channel and Sales Model Analysis
11.4.1 Fertility Enhancing Treatment Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Fertility Enhancing Treatment Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Fertility Enhancing Treatment Distributors
12 Fertility Enhancing Treatment Market Dynamics
12.1 Fertility Enhancing Treatment Industry Trends
12.2 Fertility Enhancing Treatment Market Drivers
12.3 Fertility Enhancing Treatment Market Challenges
12.4 Fertility Enhancing Treatment Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
FEATURED COMPANIES
Merck
Ferring
MSD
LIVZON
Abbott
Bayer Zydus Pharma
Church Dwight
SASMAR
BioFilm
FAIRHAVEN HEALTH
The YES YES Company
List of Tables
 Table 1. Global Fertility Enhancing Treatment Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Fertility Enhancing Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Fertility Enhancing Treatment Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Fertility Enhancing Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Fertility Enhancing Treatment Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 6. Global Fertility Enhancing Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 7. Global Fertility Enhancing Treatment Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 8. Global Fertility Enhancing Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 9. Global Fertility Enhancing Treatment Revenue Forecast by Application (2026-2031) & (US$ Million)
 Table 10. Fertility Enhancing Treatment Revenue by Company (2020-2025) & (US$ Million)
 Table 11. Fertility Enhancing Treatment Revenue Share by Company (2020-2025)
 Table 12. Ranking of Global Top Fertility Enhancing Treatment Players by Revenue (US$ Million) in 2024
 Table 13. Global Fertility Enhancing Treatment Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 14. Global Fertility Enhancing Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fertility Enhancing Treatment as of 2024)
 Table 15. Global Fertility Enhancing Treatment Companies Headquarters
 Table 16. Date of International Companies Enter into Fertility Enhancing Treatment Market
 Table 17. Global Fertility Enhancing Treatment Companies Product & Service
 Table 18. Global Fertility Enhancing Treatment Mergers & Acquisitions, Expansion Plans
 Table 19. Merck Corporation Information
 Table 20. Merck Description and Business Overview
 Table 21. Merck Fertility Enhancing Treatment Product
 Table 22. Merck Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 23. Merck Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 24. Merck Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 25. Merck Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 26. Merck Recent Developments
 Table 27. Ferring Corporation Information
 Table 28. Ferring Description and Business Overview
 Table 29. Ferring Fertility Enhancing Treatment Product
 Table 30. Ferring Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 31. Ferring Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 32. Ferring Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 33. Ferring Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 34. Ferring Recent Developments
 Table 35. MSD Corporation Information
 Table 36. MSD Description and Business Overview
 Table 37. MSD Fertility Enhancing Treatment Product
 Table 38. MSD Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 39. MSD Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 40. MSD Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 41. MSD Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 42. MSD Recent Developments
 Table 43. LIVZON Corporation Information
 Table 44. LIVZON Description and Business Overview
 Table 45. LIVZON Fertility Enhancing Treatment Product
 Table 46. LIVZON Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 47. LIVZON Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 48. LIVZON Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 49. LIVZON Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 50. LIVZON Recent Developments
 Table 51. Abbott Corporation Information
 Table 52. Abbott Description and Business Overview
 Table 53. Abbott Fertility Enhancing Treatment Product
 Table 54. Abbott Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 55. Abbott Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 56. Abbott Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 57. Abbott Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 58. Abbott Recent Developments
 Table 59. Bayer Zydus Pharma Corporation Information
 Table 60. Bayer Zydus Pharma Description and Business Overview
 Table 61. Bayer Zydus Pharma Fertility Enhancing Treatment Product
 Table 62. Bayer Zydus Pharma Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 63. Bayer Zydus Pharma Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 64. Bayer Zydus Pharma Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 65. Bayer Zydus Pharma Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 66. Bayer Zydus Pharma Recent Developments
 Table 67. Church＆Dwight Corporation Information
 Table 68. Church＆Dwight Description and Business Overview
 Table 69. Church＆Dwight Fertility Enhancing Treatment Product
 Table 70. Church＆Dwight Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 71. Church＆Dwight Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 72. Church＆Dwight Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 73. Church＆Dwight Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 74. Church＆Dwight Recent Developments
 Table 75. SASMAR Corporation Information
 Table 76. SASMAR Description and Business Overview
 Table 77. SASMAR Fertility Enhancing Treatment Product
 Table 78. SASMAR Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 79. SASMAR Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 80. SASMAR Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 81. SASMAR Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 82. SASMAR Recent Developments
 Table 83. BioFilm,Inc Corporation Information
 Table 84. BioFilm,Inc Description and Business Overview
 Table 85. BioFilm,Inc Fertility Enhancing Treatment Product
 Table 86. BioFilm,Inc Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 87. BioFilm,Inc Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 88. BioFilm,Inc Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 89. BioFilm,Inc Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 90. BioFilm,Inc Recent Developments
 Table 91. FAIRHAVEN HEALTH Corporation Information
 Table 92. FAIRHAVEN HEALTH Description and Business Overview
 Table 93. FAIRHAVEN HEALTH Fertility Enhancing Treatment Product
 Table 94. FAIRHAVEN HEALTH Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 95. FAIRHAVEN HEALTH Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 96. FAIRHAVEN HEALTH Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 97. FAIRHAVEN HEALTH Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 98. FAIRHAVEN HEALTH Recent Developments
 Table 99. The YES YES Company Corporation Information
 Table 100. The YES YES Company Description and Business Overview
 Table 101. The YES YES Company Fertility Enhancing Treatment Product
 Table 102. The YES YES Company Fertility Enhancing Treatment Revenue (US$ Million) and Gross Margin (2020-2025)
 Table 103. The YES YES Company Revenue Proportion of Fertility Enhancing Treatment by Product in 2024
 Table 104. The YES YES Company Revenue Proportion of Fertility Enhancing Treatment by Application in 2024
 Table 105. The YES YES Company Revenue Proportion of Fertility Enhancing Treatment by Geographic Area in 2024
 Table 106. The YES YES Company Recent Developments
 Table 107. North America Fertility Enhancing Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 108. North America Fertility Enhancing Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 109. North America Fertility Enhancing Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 110. North America Fertility Enhancing Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 111. Asia-Pacific Fertility Enhancing Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 112. Asia-Pacific Fertility Enhancing Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 113. Asia-Pacific Fertility Enhancing Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 114. Asia-Pacific Fertility Enhancing Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 115. Europe Fertility Enhancing Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 116. Europe Fertility Enhancing Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 117. Europe Fertility Enhancing Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 118. Europe Fertility Enhancing Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 119. Latin America Fertility Enhancing Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 120. Latin America Fertility Enhancing Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 121. Latin America Fertility Enhancing Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 122. Latin America Fertility Enhancing Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 123. Middle East and Africa Fertility Enhancing Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 124. Middle East and Africa Fertility Enhancing Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 125. Middle East and Africa Fertility Enhancing Treatment Revenue by Type (2020-2025) & (US$ Million)
 Table 126. Middle East and Africa Fertility Enhancing Treatment Revenue by Application (2020-2025) & (US$ Million)
 Table 127. Fertility Enhancing Treatment Key Raw Materials, Industry Status and Trend
 Table 128. Fertility Enhancing Treatment Key Raw Materials and Upstream Suppliers
 Table 129. Fertility Enhancing Treatment Clients Status and Trend
 Table 130. Fertility Enhancing Treatment Typical Clients
 Table 131. Fertility Enhancing Treatment Distributors
 Table 132. Fertility Enhancing Treatment Market Trends
 Table 133. Fertility Enhancing Treatment Market Drivers
 Table 134. Fertility Enhancing Treatment Market Challenges
 Table 135. Fertility Enhancing Treatment Market Restraints
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources


List of Figures
 Figure 1. Fertility Enhancing Treatment Product Picture
 Figure 2. Global Fertility Enhancing Treatment Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Fertility Enhancing Treatment Revenue Market Share by Type in 2024 & 2031
 Figure 4. Fertility Drugs for Women Product Picture
 Figure 5. Fertility Drugs for Men Product Picture
 Figure 6. OTC Conception Gels/Lubricants Product Picture
 Figure 7. Global Fertility Enhancing Treatment Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 8. Global Fertility Enhancing Treatment Revenue Market Share by Application in 2024 & 2031
 Figure 9. Hospitals
 Figure 10. Drug Stores
 Figure 11. Online
 Figure 12. Fertility Enhancing Treatment Report Years Considered
 Figure 13. Global Fertility Enhancing Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Fertility Enhancing Treatment Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Fertility Enhancing Treatment Market Size Market Share by Region: 2024 Versus 2031
 Figure 16. Global Fertility Enhancing Treatment Revenue Market Share by Region (2020-2031)
 Figure 17. Global Fertility Enhancing Treatment Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Global Fertility Enhancing Treatment Revenue Market Share Forecast by Application (2020-2031)
 Figure 19. Fertility Drugs for Women of Fertility Enhancing Treatment Revenue Market Share by Application, 2024 VS 2031
 Figure 20. Fertility Drugs for Men of Fertility Enhancing Treatment Revenue Market Share by Application, 2024 VS 2031
 Figure 21. OTC Conception Gels/Lubricants of Fertility Enhancing Treatment Revenue Market Share by Application, 2024 VS 2031
 Figure 22. Fertility Enhancing Treatment Revenue Share by Company (2024)
 Figure 23. Fertility Enhancing Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Fertility Drugs for Women Revenue Proportion by Company in 2024
 Figure 25. Fertility Drugs for Men Revenue Proportion by Company in 2024
 Figure 26. OTC Conception Gels/Lubricants Revenue Proportion by Company in 2024
 Figure 27. North America Fertility Enhancing Treatment Revenue 2020-2031 (US$ Million)
 Figure 28. North America Fertility Enhancing Treatment Revenue Market Share by Type (2020-2025)
 Figure 29. North America Fertility Enhancing Treatment Revenue Market Share by Application (2020-2025)
 Figure 30. Asia-Pacific Fertility Enhancing Treatment Revenue 2020-2031 (US$ Million)
 Figure 31. Asia-Pacific Fertility Enhancing Treatment Revenue Market Share by Region (2020-2031)
 Figure 32. Asia-Pacific Fertility Enhancing Treatment Revenue Market Share by Type (2020-2025)
 Figure 33. Asia-Pacific Fertility Enhancing Treatment Revenue Market Share by Application (2020-2025)
 Figure 34. Europe Fertility Enhancing Treatment Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 35. Europe Fertility Enhancing Treatment Revenue Market Share by Country (2020-2031)
 Figure 36. Europe Fertility Enhancing Treatment Revenue Market Share by Type (2020-2025)
 Figure 37. Europe Fertility Enhancing Treatment Revenue Market Share by Application (2020-2025)
 Figure 38. Latin America Fertility Enhancing Treatment Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 39. Latin America Fertility Enhancing Treatment Revenue Market Share by Country (2020-2031)
 Figure 40. Latin America Fertility Enhancing Treatment Revenue Market Share by Type (2020-2025)
 Figure 41. Latin America Fertility Enhancing Treatment Revenue Market Share by Application (2020-2025)
 Figure 42. Middle East and Africa Fertility Enhancing Treatment Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Middle East and Africa Fertility Enhancing Treatment Revenue Market Share by Country (2020-2031)
 Figure 44. Middle East and Africa Fertility Enhancing Treatment Revenue Market Share by Type (2020-2025)
 Figure 45. Middle East and Africa Fertility Enhancing Treatment Revenue Market Share by Application (2020-2025)
 Figure 46. Fertility Enhancing Treatment Supply Chain (Upstream and Downstream Market)
 Figure 47. Global Production Market Share of Fertility Enhancing Treatment Raw Materials by Region in 2024
 Figure 48. Fertility Enhancing Treatment Distribution Channels
 Figure 49. Global Fertility Enhancing Treatment Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 50. Global Fertility Enhancing Treatment Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 51. Bottom-up and Top-down Approaches for This Report
 Figure 52. Data Triangulation
 Figure 53. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Infertility Drugs Market Size Manufacturers Supply Chain Sales Channel and Clients 2024 2030
Global Infertility Treatment Drugs Market Insights Forecast to 2030
Female Infertility Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Fertility Drugs Market Insights Forecast to 2030
Global Ovulation Inducing Drugs Market Research Report 2024
Global Injectable Fertility Medications Market Research Report 2024
Global Assisted Reproductive Medications Market Research Report 2024
Assisted Reproductive Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injectable IVF Medications Market Research Report 2024
Global Female Infertility Drugs Market Insights Forecast to 2030
Assisted Reproductive Technologies Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Assisted Reproductive Technologies Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Infertility Services Market Research Report 2024
Global Infertility Therapies Market Insights Forecast to 2030
Global Assisted Reproductive Treatment Market Research Report 2024
Global Hormonal Infertility Treatment Market Research Report 2022
Global Clomiphene Citrate Market Research Report 2024
In Vitro Fertilization IVF Treatment Market
Global Non injectable GnRH Drugs Market Research Report 2024
Global Infertility Devices Market Insights Forecast to 2030

RELATED REPORTS

Global Microfluidic in Vitro Diagnostics Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24Z19487
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Yohimbe Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34B2983
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Erection Rings Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19V3238
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Sperm Bank Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35F5845
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions